Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayesh Mehta

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Leukemia|August 18, 2020
COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matterAnkur Varma, Satyajit Kosuri, Celalettin Ustun, et al.
Cancer|March 14, 2007
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipientsSteve Trifilio, Gennethel Pennick, Judy Pi, et al.
Blood|May 27, 2008
First thalidomide clinical trial in multiple myeloma: a decadeFrits van Rhee, Madhav Dhodapkar, John D Shaughnessy, et al.
British Journal of Haematology|December 29, 2007
A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphomaAndrew M Evens, Jane N Winter, Nanjiang Hou, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2019
Patterns of Failure and Survival Outcomes after Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin LymphomaNitika Paudel, Derek Schulze, Ryan D Gentzler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 2016
Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic MalignanciesMarcelo C Pasquini, Jennifer Le-Rademacher, Xiaochun Zhu, et al.
British Journal of Haematology|March 22, 2003
Infection--an underappreciated cause of bone pain in multiple myelomaRaman Desikan, Bart Barlogie, Rajesh Sethi, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 21, 2015
Adverse Events During Hematopoietic Stem Cell Infusion: Analysis of the Infusion ProductNeelima Vidula, Marcelo Villa, Irene B Helenowski, et al.
Leukemia & Lymphoma|January 8, 2025
Variance in development of early and late cardiotoxicities in patients with lymphoma and myeloma receiving CAR T-cell therapiesEli Grunblatt, Zhiying Meng, Abigail S Baldridge, et al.
Blood|March 22, 2007
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remissionMartin S Tallman, Gordon W Dewald, Sharavi Gandham, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Leukemia|August 18, 2020
COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matterAnkur Varma, Satyajit Kosuri, Celalettin Ustun, et al.
Cancer|March 14, 2007
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipientsSteve Trifilio, Gennethel Pennick, Judy Pi, et al.
Blood|May 27, 2008
First thalidomide clinical trial in multiple myeloma: a decadeFrits van Rhee, Madhav Dhodapkar, John D Shaughnessy, et al.
British Journal of Haematology|December 29, 2007
A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphomaAndrew M Evens, Jane N Winter, Nanjiang Hou, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2019
Patterns of Failure and Survival Outcomes after Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin LymphomaNitika Paudel, Derek Schulze, Ryan D Gentzler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 2016
Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic MalignanciesMarcelo C Pasquini, Jennifer Le-Rademacher, Xiaochun Zhu, et al.
British Journal of Haematology|March 22, 2003
Infection--an underappreciated cause of bone pain in multiple myelomaRaman Desikan, Bart Barlogie, Rajesh Sethi, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 21, 2015
Adverse Events During Hematopoietic Stem Cell Infusion: Analysis of the Infusion ProductNeelima Vidula, Marcelo Villa, Irene B Helenowski, et al.
Leukemia & Lymphoma|January 8, 2025
Variance in development of early and late cardiotoxicities in patients with lymphoma and myeloma receiving CAR T-cell therapiesEli Grunblatt, Zhiying Meng, Abigail S Baldridge, et al.
Blood|March 22, 2007
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remissionMartin S Tallman, Gordon W Dewald, Sharavi Gandham, et al.
Pageof 11